BACKGROUND: Inadequate @entity158 control has a significant role in maternal and neonatal health in early post-partum period which interferes with breastfeeding and has a negative influence on @entity1 normal growth. The aim of this study is evaluation of subcutaneous @entity284 effectiveness on post-operative @entity158 control. MATERIALS AND METHODS: Double blind randomized prospective clinical trial involving 60 term pregnancy @entity1 through 2008 to 2009 Undergo cesarean. INCLUSION CRITERIA: Prime gravid candidate of elective cesarean and spinal anesthesia class 1 or 2. Known case of @entity56 and @entity284 interaction, addiction, uncontrolled medical disease excluded. Case group injected 10 mg of subcutaneous @entity284 in the site of incision before final suture. @entity1286 was a @entity158 reliever in follow up examination. Data include mean of @entity158 , @entity390 and @entity391 , MAP, etc., collected and analyzed by independent-T test and @entity1 Whitney test. RESULTS: Although mean usage of @entity1286 between groups was not significant statistically but the mean @entity158 severity (P value < 0.05) and mean satisfactory (P value = 0.02) was statistically significant between groups. Other parameters were not statistically significant. CONCLUSION: We suggest subcutaneous @entity284 as a safe @entity158 reliever in post cesarean section @entity1 .

Evaluation of the analgesic effect of subcutaneous XXXX after cesarean section.

@entity1 :: ('9606', 'Species') :: ['patients', 'child', 'Man'] @entity390 :: ('MESH:D009325', 'Disease') :: ['nausea'] @entity391 :: ('MESH:D014839', 'Disease') :: ['vomiting'] @entity56 :: ('MESH:D004342', 'Disease') :: ['drug allergy'] @entity284 :: ('MESH:D008691', 'Chemical') :: ['methadone'] @entity1286 :: ('MESH:D009020', 'Chemical') :: ['morphine', 'Morphine'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain']
@entity284 :: (MESH:D008691,Chemical) :: ['methadone']
